NeuroOne Medical Technologies Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
14.3%projected annual EPS growth
Analyst Coverage
3analysts covering
FY EPS (est.)
-$0.69next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q4 Fiscal 2026 Earnings Release | 16 Dec 2026 |
Monitoring Framework
Key Performance Indicators
Product Revenue Quarterly5.3MTarget: At least $10.5 million for Fiscal Year 2026
Product Gross Margin Quarterly5,380.0%Target: Maintain or expand above 50%
Watch Items
- Going Concern and Cash RunwayTrigger: Cash balance falling below $1.5 million without additional financingAction: Evaluate dilutive or non-dilutive capital raises, strategic partnerships, or further cost-reduction measures to extend runway beyond September 2026.
- Internal Controls over Financial ReportingTrigger: Further material weaknesses or restatements identified in customer purchase order trackingAction: Implement and audit enhanced reconciliation and review controls for modified customer purchase orders under ASC 606.
- Zimmer Biomet Distribution PerformanceTrigger: Significant drop in order volume or sequential decline in OneRF product salesAction: Re-engage with Zimmer Biomet to optimize commercialization strategies and review minimum purchase commitments.
Research as of 20 Jun 2026